Mesoblast (MESO) Operating Leases (2019 - 2025)
Mesoblast (MESO) posted quarterly Operating Leases of $5.9 million for Q4 2025, up 24.04% year-on-year from $4.8 million in Q4 2024, and up 64.44% on a QoQ basis from $3.6 million in Q2 2025.
Mesoblast (MESO) Operating Leases (2019 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Operating Leases for 7 consecutive years, with $5.9 million the latest figure, recorded in Q4 2025.
- Quarterly Operating Leases rose 24.04% year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (up 24.04% YoY) and the FY2025 annual result came in at $3.6 million, down 21.73% from the prior year.
- Operating Leases climbed to $5.9 million in Q4 2025 per MESO's latest filing, from $3.6 million in the prior quarter.
- Over the last five years, Operating Leases for MESO reached as high as $10.3 million in Q2 2022 and fell as low as $3.4 million in Q4 2023.
- A 5-year average of $6.3 million and a median of $6.3 million in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases sank 42.29% — and 2024, when it surged 40.28%.
- Year by year, Operating Leases stood at $7.9 million in 2021, then tumbled by 37.04% to $5.0 million in 2022, then sank by 32.28% to $3.4 million in 2023, then surged by 40.28% to $4.8 million in 2024, then gained by 24.04% to $5.9 million in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $5.9 million, $3.6 million, and $4.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.89 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Jun 30, 2024 | 4.58 Mn |
| Dec 31, 2023 | 3.39 Mn |
| Jun 30, 2023 | 7.73 Mn |
| Mar 31, 2023 | 4.65 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Jun 30, 2022 | 10.27 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 7.56 Mn |
| Jun 30, 2021 | 8.49 Mn |
| Mar 31, 2021 | 6.48 Mn |
| Dec 31, 2020 | 6.51 Mn |
| Sep 30, 2020 | 7.05 Mn |
| Jun 30, 2020 | 6.32 Mn |
| Mar 31, 2020 | 5.76 Mn |
| Dec 31, 2019 | 6.68 Mn |